SBRVX
Price
$14.88
Change
-$0.35 (-2.30%)
Updated
Feb 21 closing price
Net Assets
509.17M
VSMAX
Price
$114.81
Change
-$3.10 (-2.63%)
Updated
Feb 21 closing price
Net Assets
160.88B
Ad is loading...

SBRVX vs VSMAX

Header iconSBRVX vs VSMAX Comparison
Open Charts SBRVX vs VSMAXBanner chart's image
Segall Bryant & Hamill Sm Cp Val Ret
Price$14.88
Change-$0.35 (-2.30%)
VolumeN/A
Net Assets509.17M
Vanguard Small Cap Index Admiral Shares
Price$114.81
Change-$3.10 (-2.63%)
VolumeN/A
Net Assets160.88B
SBRVX vs VSMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SBRVX vs. VSMAX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SBRVX is a StrongBuy and VSMAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 161B vs. SBRVX (509M). VSMAX pays higher dividends than SBRVX: VSMAX (1.42) vs SBRVX (1.19). SBRVX was incepted earlier than VSMAX: SBRVX (5 years) vs VSMAX (24 years). SBRVX is a more actively managed with annual turnover of: 35.00 vs. VSMAX (12.00). SBRVX has a lower initial minimum investment than VSMAX: SBRVX (2500) vs VSMAX (3000). VSMAX annual gain was more profitable for investors over the last year : 14.26 vs. SBRVX (12.96). VSMAX return over 5 years is better than : 48.38 vs. SBRVX (26.66).
SBRVXVSMAXSBRVX / VSMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years24 years-
Gain YTD3.0302.388127%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets509M161B0%
Annual Yield % from dividends1.191.4284%
Returns for 1 year12.9614.2691%
Returns for 3 years9.9922.0745%
Returns for 5 years26.6648.3855%
Returns for 10 yearsN/A111.34-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMIRX18.74N/A
N/A
Franklin International Equity R
PRHSX83.57N/A
N/A
T. Rowe Price Health Sciences
FBSAX38.42N/A
N/A
Franklin Mutual U.S. Mid Cap Value Adv
RGSCX23.24N/A
N/A
Virtus KAR Global Small-Cap C
BREUX41.66N/A
N/A
Baron Real Estate R6